Topical NF-kappaB Decoy in the Treatment of Atopic Dermatitis
Status:
Completed
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether this topical NF-kappaB Decoy candidate is
safe in persons with atopic dermatitis. Preliminary evidence of efficacy (whether it is
working) will also be evaluated.